These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1056 related items for PubMed ID: 1968930

  • 1. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y, Mayumi H, Eto M, Nomoto K.
    J Immunol; 1990 Mar 15; 144(6):2425-35. PubMed ID: 1968930
    [Abstract] [Full Text] [Related]

  • 2. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H.
    J Immunol; 1989 Sep 01; 143(5):1447-52. PubMed ID: 2527264
    [Abstract] [Full Text] [Related]

  • 3. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A, Kruisbeek AM, Andrysiak PM.
    J Immunol; 1984 May 01; 132(5):2199-209. PubMed ID: 6201534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S, Kitagawa S, Iwata H, Ochiai T, Isono K, Hamaoka T, Fujiwara H.
    J Exp Med; 1992 Jan 01; 175(1):99-109. PubMed ID: 1730930
    [Abstract] [Full Text] [Related]

  • 6. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A, Shiku H, Nakayama E.
    J Immunol; 1993 Jun 01; 150(11):4900-10. PubMed ID: 8496592
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
    Kitagawa S, Sato S, Azuma T, Shimizu J, Hamaoka T, Fujiwara H.
    J Immunol; 1991 Apr 15; 146(8):2513-21. PubMed ID: 1673140
    [Abstract] [Full Text] [Related]

  • 8. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
    Cassell D, Forman J.
    J Immunol; 1991 Jan 01; 146(1):3-10. PubMed ID: 1670605
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S.
    Eur J Immunol; 1991 Sep 01; 21(9):2095-103. PubMed ID: 1679712
    [Abstract] [Full Text] [Related]

  • 10. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S, Azuma T, Shimizu J, Shima J, Kitagawa S, Hamaoka T, Fujiwara H.
    J Immunol; 1988 Aug 01; 141(3):721-7. PubMed ID: 2456330
    [Abstract] [Full Text] [Related]

  • 11. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S, Brighouse G, Kramer G, Wen L, Izui S, Merino J, Lambert PH.
    J Immunol; 1991 Apr 01; 146(7):2152-60. PubMed ID: 1672344
    [Abstract] [Full Text] [Related]

  • 12. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
    Azuma T, Sato S, Kitagawa S, Hori S, Kokudo S, Hamaoka T, Fujiwara H.
    J Immunol; 1989 Jul 01; 143(1):1-8. PubMed ID: 2525143
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H, Hino T, Kato H, Suzuki H, Saito K.
    J Immunol; 1986 Oct 01; 137(7):2080-8. PubMed ID: 3489752
    [Abstract] [Full Text] [Related]

  • 14. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K.
    J Immunol; 1990 Dec 15; 145(12):4026-36. PubMed ID: 2147933
    [Abstract] [Full Text] [Related]

  • 15. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK, Shelby J, Eichwald EJ.
    Transplantation; 1992 Apr 15; 53(4):849-57. PubMed ID: 1533070
    [Abstract] [Full Text] [Related]

  • 16. Assessment of alloreactive T cell subpopulations of aged mice in vivo. CD4+ but not CD8+ T cell-mediated rejection response declines with advanced age.
    Rosenberg AS, Sechler JM, Horvath JA, Maniero TG, Bloom ET.
    Eur J Immunol; 1994 Jun 15; 24(6):1312-6. PubMed ID: 7911422
    [Abstract] [Full Text] [Related]

  • 17. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG, Liu Z, Wu Y.
    Transpl Immunol; 2005 Oct 15; 15(1):9-16. PubMed ID: 16223668
    [Abstract] [Full Text] [Related]

  • 18. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K, Nakashima I, Nagase F, Isobe K, Kawashima K, Hasegawa Y, Yoshida T, Iwamoto T, Hasegawa T, Muro Y.
    J Immunol; 1988 Feb 01; 140(3):723-9. PubMed ID: 2448374
    [Abstract] [Full Text] [Related]

  • 19. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH, Ngo K, Fung-Leung WP.
    Eur J Immunol; 1996 Jan 01; 26(1):213-8. PubMed ID: 8566069
    [Abstract] [Full Text] [Related]

  • 20. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL, Forman J.
    J Immunol; 1990 Mar 01; 144(5):2018-26. PubMed ID: 1968493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.